DE BACKER MARIANNE (Chief Executive Officer) sold 7.1% of their position (72.56K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $664.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/7/2026ACC: 0001628280-26-024098
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-72.56K
Net shares
Net seller
$664.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
72.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−72.56K
Price / share
$9.16
Trade value
$664.35K
% of position
7.1%
4/6/2026
1.02M→948.14K
Total
Net shares
−72.56K
Net value
-$664.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | S · Sale | −72.56K | $9.16 | $664.35K | 7.1% | 1.02M | 948.14K |
| Total | −72.56K | -$664.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned53.12K
Total
53.12K indirect53.12K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 53.12K | Indirect |
| Total | 53.12K | 53.12K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported